Log In
Print
BCIQ
Print
Print this Print this
 

AD02

  Manage Alerts
Collapse Summary General Information
Company Affiris AG
DescriptionVaccine against beta amyloid composed of a peptide antigen combined with a carrier molecule and adjuvant
Molecular Target Beta amyloid
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD); Treat early Alzheimer's disease (AD); Treat mild to moderate Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today